GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut. Show more
Location: North Tower, Stamford, CT, 06902, United States | Website: https://www.genedx.com | Industry: Diagnostics & Research | Sector: Healthcare
Market Cap
2.356B
52 Wk Range
$25.32 - $117.75
Previous Close
$86.91
Open
$86.60
Volume
888,452
Day Range
$82.40 - $87.02
Enterprise Value
2.59B
Cash
159.2M
Avg Qtr Burn
-475.3K
Insider Ownership
12.56%
Institutional Own.
-
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|